|Articles|November 9, 2021
- Pharmaceutical Executive-11-01-2021
- Volume 41
- Issue 11
Pharmaceutical Executive, November 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 5 years ago
In It For the Long-Haul: Planning for the Future of COVID-19almost 5 years ago
Turning the Corner: A New Era of Pharma Sales Comes Into Viewalmost 5 years ago
An Industry Under Attack: Pharma Revisits Cybersecurity During COVID-19almost 5 years ago
The New COVID Workforce: Keeping Pharma Strong Through Adversityalmost 5 years ago
Crafting Curesalmost 5 years ago
Could 2022 Prove to Be Better Year for Biotech Companies?almost 5 years ago
COVID and the Data Talent Turnaboutalmost 5 years ago
Talent Pipelines Can Position Companies for Greater Hiring Successalmost 5 years ago
EU MEPs Arrive At Crossroads in Cancer Strategyalmost 5 years ago
Pharm Exec at 40 (2015-2018)Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5

